Literature DB >> 12509454

p21(CIP1) Controls proliferating cell nuclear antigen level in adult cardiomyocytes.

Felix B Engel1, Ludger Hauck, Manfred Boehm, Elizabeth G Nabel, Rainer Dietz, Rüdiger von Harsdorf.   

Abstract

Cell cycle withdrawal associated with terminal differentiation is responsible for the incapability of many organs to regenerate after injury. Here, we employed a cell-free system to analyze the molecular mechanisms underlying cell cycle arrest in cardiomyocytes. In this assay, incubation of S phase nuclei mixed with cytoplasmic extract of S phase cells and adult primary cardiomyocytes results in a dramatic reduction of proliferating cell nuclear antigen (PCNA) protein levels. This effect was blocked by the proteasome inhibitors MG132 and lactacystin, whereas actinomycin D and cycloheximide had no effect. Immunodepletion and addback experiments revealed that the effect of cardiomyocyte extract on PCNA protein levels is maintained by p21 but not p27. In serum-stimulated cardiomyocytes PCNA expression was reconstituted, whereas the protein level of p21 but not that of p27 was reduced. Cytoplasmic extract of serum-stimulated cardiomyocytes did not influence the PCNA protein level in S phase nuclei. Moreover, the hypertrophic effect of serum stimulation was blocked by ectopic expression of p21 and the PCNA protein level was found to be upregulated in adult cardiomyocytes derived from p21 knockout mice. Our data provide evidence that p21 regulates the PCNA protein level in adult cardiomyocytes, which has implications for cardiomyocyte growth control.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12509454      PMCID: PMC151523          DOI: 10.1128/MCB.23.2.555-565.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  65 in total

1.  A mammalian myocardial cell-free system to study cell cycle reentry in terminally differentiated cardiomyocytes.

Authors:  F B Engel; L Hauck; M C Cardoso; H Leonhardt; R Dietz; R von Harsdorf
Journal:  Circ Res       Date:  1999-08-06       Impact factor: 17.367

2.  Dynamics of early contact formation in cultured adult rat cardiomyocytes studied by N-cadherin fused to green fluorescent protein.

Authors:  C Zuppinger; M C Schaub; H M Eppenberger
Journal:  J Mol Cell Cardiol       Date:  2000-04       Impact factor: 5.000

3.  Inhibitory function of p21Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control.

Authors:  F Di Cunto; G Topley; E Calautti; J Hsiao; L Ong; P K Seth; G P Dotto
Journal:  Science       Date:  1998-05-15       Impact factor: 47.728

Review 4.  Multiple roles of the proliferating cell nuclear antigen: DNA replication, repair and cell cycle control.

Authors:  E Prosperi
Journal:  Prog Cell Cycle Res       Date:  1997

5.  Hypertrophy, pathology, and molecular markers of cardiac pathogenesis.

Authors:  K L Vikstrom; T Bohlmeyer; S M Factor; L A Leinwand
Journal:  Circ Res       Date:  1998-04-20       Impact factor: 17.367

6.  Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH(2)-terminal kinases.

Authors:  G Choukroun; R Hajjar; S Fry; F del Monte; S Haq; J L Guerrero; M Picard; A Rosenzweig; T Force
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

7.  Cardiac mitogen-activated protein kinase activities are chronically increased in stroke-prone hypertensive rats.

Authors:  Y Izumi; S Kim; T Murakami; S Yamanaka; H Iwao
Journal:  Hypertension       Date:  1998-01       Impact factor: 10.190

8.  The lack of a functional p21(WAF1/CIP1) gene ameliorates progression to chronic renal failure.

Authors:  J Megyesi; P M Price; E Tamayo; R L Safirstein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

9.  Myocyte proliferation in end-stage cardiac failure in humans.

Authors:  J Kajstura; A Leri; N Finato; C Di Loreto; C A Beltrami; P Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

10.  p21 and retinoblastoma protein control the absence of DNA replication in terminally differentiated muscle cells.

Authors:  A Mal; D Chattopadhyay; M K Ghosh; R Y Poon; T Hunter; M L Harter
Journal:  J Cell Biol       Date:  2000-04-17       Impact factor: 10.539

View more
  22 in total

1.  Neuregulin stimulation of cardiomyocyte regeneration in mice and human myocardium reveals a therapeutic window.

Authors:  Brian D Polizzotti; Balakrishnan Ganapathy; Stuart Walsh; Sangita Choudhury; Niyatie Ammanamanchi; David G Bennett; Cristobal G dos Remedios; Bernhard J Haubner; Josef M Penninger; Bernhard Kühn
Journal:  Sci Transl Med       Date:  2015-04-01       Impact factor: 17.956

2.  p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes.

Authors:  Felix B Engel; Michael Schebesta; Mychelle T Duong; Gang Lu; Shuxun Ren; Jeffery B Madwed; Huiping Jiang; Yibin Wang; Mark T Keating
Journal:  Genes Dev       Date:  2005-05-03       Impact factor: 11.361

3.  p21Cip1 protection against hyperoxia requires Bcl-XL and is uncoupled from its ability to suppress growth.

Authors:  Peter F Vitiello; Rhonda J Staversky; Sean C Gehen; Carl J Johnston; Jacob N Finkelstein; Terry W Wright; Michael A O'Reilly
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

4.  hSMG-1 and ATM sequentially and independently regulate the G1 checkpoint during oxidative stress.

Authors:  S C Gehen; R J Staversky; R A Bambara; P C Keng; M A O'Reilly
Journal:  Oncogene       Date:  2008-03-10       Impact factor: 9.867

Review 5.  Understanding cardiomyocyte proliferation: an insight into cell cycle activity.

Authors:  Murugavel Ponnusamy; Pei-Feng Li; Kun Wang
Journal:  Cell Mol Life Sci       Date:  2016-09-30       Impact factor: 9.261

6.  Knockdown of cyclin-dependent kinase inhibitors induces cardiomyocyte re-entry in the cell cycle.

Authors:  Valeria Di Stefano; Mauro Giacca; Maurizio C Capogrossi; Marco Crescenzi; Fabio Martelli
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

7.  A methionine aminopeptidase-2 inhibitor, PPI-2458, for the treatment of rheumatoid arthritis.

Authors:  Sylvie G Bernier; Douglas D Lazarus; Edward Clark; Beth Doyle; Matthew T Labenski; Charles D Thompson; William F Westlin; Gerhard Hannig
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

8.  Cardiac deletion of Smyd2 is dispensable for mouse heart development.

Authors:  Florian Diehl; Mark A Brown; Machteld J van Amerongen; Tatyana Novoyatleva; Astrid Wietelmann; June Harriss; Fulvia Ferrazzi; Thomas Böttger; Richard P Harvey; Philip W Tucker; Felix B Engel
Journal:  PLoS One       Date:  2010-03-17       Impact factor: 3.240

9.  Location of cell cycle regulators cyclin B1, cyclin A, PCNA, Ki67 and cell cycle inhibitors p21, p27 and p57 in human first trimester placenta and deciduas.

Authors:  Emin Türkay Korgun; Ciler Celik-Ozenci; Nuray Acar; Sevil Cayli; Gernot Desoye; Ramazan Demir
Journal:  Histochem Cell Biol       Date:  2006-02-21       Impact factor: 4.304

10.  Lung specific expression of a human mutant p53 affects cell proliferation in transgenic mice.

Authors:  Wenrui Duan; Li Gao; David Jin; Gregory A Otterson; Miguel A Villalona-Calero
Journal:  Transgenic Res       Date:  2007-10-30       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.